Novartis Motion Is Wolf In Sheep's Clothing: Plaintiffs

Law360, New York (September 4, 2007, 12:00 AM EDT) -- Plaintiffs in the consolidated litigation over bone drugs Aredia and Zometa have slammed Novartis Pharmaceutical Corp.'s bid to break up their proposed classes as a veiled move for dismissal.

The suits, now consolidated in a Nashville district court, all accuse Novartis of strict liability and negligence in the production and distribution of the two drugs, which have been linked to osteonecrosis of the jaw, a condition involving painful deterioration of the jawbone.

In Wood v. Novartis, which concerned patients who had taken Aredia, and in Becker...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.